|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q40058952
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235751.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q40058952
|
|
024
|
|
|
‡a
0000-0002-0274-106X
‡2
orcid
|
|
024
|
|
|
‡a
7102012951
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q40058952
|
|
100
|
0 |
|
‡a
Maria P. Ferraz
‡9
sl
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Maria P. Ferraz
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Maria P. Ferraz
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Maria P. Ferraz
‡c
investigadora
‡9
es
|
|
400
|
0 |
|
‡a
Maria P. Ferraz
‡c
investigadora
‡9
ast
|
|
670
|
|
|
‡a
Author's A Cyclam Salt as an Antifungal Agent: Interference with Candida spp. and Cryptococcus neoformans Mechanisms of Virulence
|
|
670
|
|
|
‡a
Author's A modular reactor to simulate biofilm development in orthopedic materials
|
|
670
|
|
|
‡a
Author's Adhesion of Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa onto nanohydroxyapatite as a bone regeneration material.
|
|
670
|
|
|
‡a
Author's Alginate-nanohydroxyapatite hydrogel system: Optimizing the formulation for enhanced bone regeneration
|
|
670
|
|
|
‡a
Author's Anti-sessile bacterial and cytocompatibility properties of CHX-loaded nanohydroxyapatite.
|
|
670
|
|
|
‡a
Author's Antibacterial activity and biocompatibility of three-dimensional nanostructured porous granules of hydroxyapatite and zinc oxide nanoparticles--an in vitro and in vivo study.
|
|
670
|
|
|
‡a
Author's Antibacterial silk fibroin/nanohydroxyapatite hydrogels with silver and gold nanoparticles for bone regeneration
|
|
670
|
|
|
‡a
Author's Biocompatibility of highly macroporous ceramic scaffolds: cell adhesion and morphology studies
|
|
670
|
|
|
‡a
Author's Biological evaluation of alginate-based hydrogels, with antimicrobial features by Ce(III) incorporation, as vehicles for a bone substitute.
|
|
670
|
|
|
‡a
Author's CaO-P2O5 glass hydroxyapatite double-layer plasma-sprayed coating: in vitro bioactivity evaluation
|
|
670
|
|
|
‡a
Author's Cationic liposome-DNA complexes as gene delivery vectors: Development and behaviour towards bone-like cells.
|
|
670
|
|
|
‡a
Author's Comparative study of nanohydroxyapatite microspheres for medical applications
|
|
670
|
|
|
‡a
Author's Degradation Studies and Biological Behavior on an Artificial Cornea Material
|
|
670
|
|
|
‡a
Author's Development of silk fibroin/nanohydroxyapatite composite hydrogels for bone tissue engineering
|
|
670
|
|
|
‡a
Author's Effect of chemical composition on hydrophobicity and zeta potential of plasma sprayed HA/CaO–P2O5 glass coatings
|
|
670
|
|
|
‡a
Author's Equisetum arvense hydromethanolic extracts in bone tissue regeneration: in vitro osteoblastic modulation and antibacterial activity.
|
|
670
|
|
|
‡a
Author's Flow cytometry analysis of effects of glass on response of osteosarcoma cells to plasma-sprayed hydroxyapatite/CaO-P2O5 coatings
|
|
670
|
|
|
‡a
Author's Flow cytometry analysis of the effects of pre-immersion on the biocompatibility of glass-reinforced hydroxyapatite plasma-sprayed coatings
|
|
670
|
|
|
‡a
Author's HA and double-layer HA-P2O5/CaO glass coatings: influence of chemical composition on human bone marrow cells osteoblastic behavior
|
|
670
|
|
|
‡a
Author's Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering
|
|
670
|
|
|
‡a
Author's Hydroxyapatite nanoparticles: A review of preparation methodologies
|
|
670
|
|
|
‡a
Author's In vitro antimicrobial activity and biocompatibility of propolis containing nanohydroxyapatite.
|
|
670
|
|
|
‡a
Author's In vitro growth and differentiation of osteoblast-like human bone marrow cells on glass reinforced hydroxyapatite plasma-sprayed coatings.
|
|
670
|
|
|
‡a
Author's In vivoevaluation of highly macroporous ceramic scaffolds for bone tissue engineering
|
|
670
|
|
|
‡a
Author's Influence of nanohydroxyapatite surface properties on Staphylococcus epidermidis biofilm formation
|
|
670
|
|
|
‡a
Author's Laser surface treatment of hydroxyapatite for enhanced tissue integration: surface characterization and osteoblastic interaction studies.
|
|
670
|
|
|
‡a
Author's Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections
|
|
670
|
|
|
‡a
Author's Measuring Health Vulnerability: An Interdisciplinary Indicator Applied to Mainland Portugal
|
|
670
|
|
|
‡a
Author's Microanalysis of Bioactive Samarium Doped Glass-Reinforced Hydroxyapatite
|
|
670
|
|
|
‡a
Author's Micropatterned silica thin films with nanohydroxyapatite micro-aggregates for guided tissue regeneration
|
|
670
|
|
|
‡a
Author's Modulation of human dermal microvascular endothelial cell and human gingival fibroblast behavior by micropatterned silica coating surfaces for zirconia dental implant applications.
|
|
670
|
|
|
‡a
Author's Novel cerium doped glass-reinforced hydroxyapatite with antibacterial and osteoconductive properties for bone tissue regeneration.
|
|
670
|
|
|
‡a
Author's Phase Behaviour and Miscibility Studies of Collagen/Silk Fibroin Macromolecular System in Dilute Solutions and Solid State
|
|
670
|
|
|
‡a
Author's PLD bioactive ceramic films: the influence of CaO-P2O5 glass additions to hydroxyapatite on the proliferation and morphology of osteblastic like-cells.
|
|
670
|
|
|
‡a
Author's Proliferation and mineralization of bone marrow cells cultured on macroporous hydroxyapatite scaffolds functionalized with collagen type I for bone tissue regeneration
|
|
670
|
|
|
‡a
Author's Silk fibroin/nanohydroxyapatite hydrogels for promoted bioactivity and osteoblastic proliferation and differentiation of human bone marrow stromal cells
|
|
670
|
|
|
‡a
Author's Staphylococcus aureus and Escherichia coli dual-species biofilms on nanohydroxyapatite loaded with CHX or ZnO nanoparticles.
|
|
670
|
|
|
‡a
Author's Staphylococcus aureusandStaphylococcus epidermidisadhesion to nanohydroxyapatite in the presence of model proteins
|
|
670
|
|
|
‡a
Author's Supplementation of collagen scaffolds with SPARC to facilitate mineralization
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000069328312
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/100145350
|
|
909
|
|
|
‡a
(orcid) 000000020274106x
‡9
1
|
|
909
|
|
|
‡a
(scopus) 7102012951
‡9
1
|
|
919
|
|
|
‡a
antibacterialactivityandbiocompatibilityof3dimensionalnanostructuredporousgranulesofhydroxyapatiteandzincoxidenanoparticlesaninvitroandinvivostudy
‡A
Antibacterial activity and biocompatibility of three-dimensional nanostructured porous granules of hydroxyapatite and zinc oxide nanoparticles--an in vitro and in vivo study.
‡9
1
|
|
919
|
|
|
‡a
cyclamsaltasanantifungalagentinterferencewithcandidasppandcryptococcusneoformansmechanismsofvirulence
‡A
A Cyclam Salt as an Antifungal Agent: Interference with Candida spp. and Cryptococcus neoformans Mechanisms of Virulence
‡9
1
|
|
919
|
|
|
‡a
modularreactortosimulatebiofilmdevelopmentinorthopedicmaterials
‡A
A modular reactor to simulate biofilm development in orthopedic materials
‡9
1
|
|
919
|
|
|
‡a
adhesionofstaphylococcusaureusstaphylococcusepidermidisandpseudomonasaeruginosaontonanohydroxyapatiteasaboneregenerationmaterial
‡A
Adhesion of Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa onto nanohydroxyapatite as a bone regeneration material.
‡9
1
|
|
919
|
|
|
‡a
alginatenanohydroxyapatitehydrogelsystemoptimizingtheformulationforenhancedboneregeneration
‡A
Alginate-nanohydroxyapatite hydrogel system: Optimizing the formulation for enhanced bone regeneration
‡9
1
|
|
919
|
|
|
‡a
antisessilebacterialandcytocompatibilitypropertiesofchxloadednanohydroxyapatite
‡A
Anti-sessile bacterial and cytocompatibility properties of CHX-loaded nanohydroxyapatite.
‡9
1
|
|
919
|
|
|
‡a
antibacterialsilkfibroinnanohydroxyapatitehydrogelswithsilverandgoldnanoparticlesforboneregeneration
‡A
Antibacterial silk fibroin/nanohydroxyapatite hydrogels with silver and gold nanoparticles for bone regeneration
‡9
1
|
|
919
|
|
|
‡a
biocompatibilityofhighlymacroporousceramicscaffoldscelladhesionandmorphologystudies
‡A
Biocompatibility of highly macroporous ceramic scaffolds: cell adhesion and morphology studies
‡9
1
|
|
919
|
|
|
‡a
biologicalevaluationofalginatebasedhydrogelswithantimicrobialfeaturesbyce3incorporationasvehiclesforabonesubstitute
‡A
Biological evaluation of alginate-based hydrogels, with antimicrobial features by Ce(III) incorporation, as vehicles for a bone substitute.
‡9
1
|
|
919
|
|
|
‡a
caop2o5glasshydroxyapatitedoublelayerplasmasprayedcoatinginvitrobioactivityevaluation
‡A
CaO-P2O5 glass hydroxyapatite double-layer plasma-sprayed coating: in vitro bioactivity evaluation
‡9
1
|
|
919
|
|
|
‡a
cationicliposomednacomplexesasgenedeliveryvectorsdevelopmentandbehaviourtowardsbonelikecells
‡A
Cationic liposome-DNA complexes as gene delivery vectors: Development and behaviour towards bone-like cells.
‡9
1
|
|
919
|
|
|
‡a
comparativestudyofnanohydroxyapatitemicrospheresformedicalapplications
‡A
Comparative study of nanohydroxyapatite microspheres for medical applications
‡9
1
|
|
919
|
|
|
‡a
degradationstudiesandbiologicalbehavioronanartificialcorneamaterial
‡A
Degradation Studies and Biological Behavior on an Artificial Cornea Material
‡9
1
|
|
919
|
|
|
‡a
developmentofsilkfibroinnanohydroxyapatitecompositehydrogelsforbonetissueengineering
‡A
Development of silk fibroin/nanohydroxyapatite composite hydrogels for bone tissue engineering
‡9
1
|
|
919
|
|
|
‡a
effectofchemicalcompositiononhydrophobicityandzetapotentialofplasmasprayedhacaop2o5glasscoatings
‡A
Effect of chemical composition on hydrophobicity and zeta potential of plasma sprayed HA/CaO–P2O5 glass coatings
‡9
1
|
|
919
|
|
|
‡a
equisetumarvensehydromethanolicextractsinbonetissueregenerationinvitroosteoblasticmodulationandantibacterialactivity
‡A
Equisetum arvense hydromethanolic extracts in bone tissue regeneration: in vitro osteoblastic modulation and antibacterial activity.
‡9
1
|
|
919
|
|
|
‡a
flowcytometryanalysisofeffectsofglassonresponseofosteosarcomacellstoplasmasprayedhydroxyapatitecaop2o5coatings
‡A
Flow cytometry analysis of effects of glass on response of osteosarcoma cells to plasma-sprayed hydroxyapatite/CaO-P2O5 coatings
‡9
1
|
|
919
|
|
|
‡a
flowcytometryanalysisoftheeffectsofpreimmersiononthebiocompatibilityofglassreinforcedhydroxyapatiteplasmasprayedcoatings
‡A
Flow cytometry analysis of the effects of pre-immersion on the biocompatibility of glass-reinforced hydroxyapatite plasma-sprayed coatings
‡9
1
|
|
919
|
|
|
‡a
anddoublelayerhap2o5caoglasscoatingsinfluenceofchemicalcompositiononhumanbonemarrowcellsosteoblasticbehavior
‡A
HA and double-layer HA-P2O5/CaO glass coatings: influence of chemical composition on human bone marrow cells osteoblastic behavior
‡9
1
|
|
919
|
|
|
‡a
heparinizedhydroxyapatitecollagen3dimensionalscaffoldsfortissueengineering
‡A
Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering
‡9
1
|
|
919
|
|
|
‡a
hydroxyapatitenanoparticlesareviewofpreparationmethodologies
‡A
Hydroxyapatite nanoparticles: A review of preparation methodologies
‡9
1
|
|
919
|
|
|
‡a
invitroantimicrobialactivityandbiocompatibilityofpropoliscontainingnanohydroxyapatite
‡A
In vitro antimicrobial activity and biocompatibility of propolis containing nanohydroxyapatite.
‡9
1
|
|
919
|
|
|
‡a
invitrogrowthanddifferentiationofosteoblastlikehumanbonemarrowcellsonglassreinforcedhydroxyapatiteplasmasprayedcoatings
‡A
In vitro growth and differentiation of osteoblast-like human bone marrow cells on glass reinforced hydroxyapatite plasma-sprayed coatings.
‡9
1
|
|
919
|
|
|
‡a
invivoevaluationofhighlymacroporousceramicscaffoldsforbonetissueengineering
‡A
In vivoevaluation of highly macroporous ceramic scaffolds for bone tissue engineering
‡9
1
|
|
919
|
|
|
‡a
influenceofnanohydroxyapatitesurfacepropertiesonstaphylococcusepidermidisbiofilmformation
‡A
Influence of nanohydroxyapatite surface properties on Staphylococcus epidermidis biofilm formation
‡9
1
|
|
919
|
|
|
‡a
lasersurfacetreatmentofhydroxyapatiteforenhancedtissueintegrationsurfacecharacterizationandosteoblasticinteractionstudies
‡A
Laser surface treatment of hydroxyapatite for enhanced tissue integration: surface characterization and osteoblastic interaction studies.
‡9
1
|
|
919
|
|
|
‡a
lyticbacteriophagesagainstmultidrugresistantstaphylococcusaureusenterococcusfaecalisandescherichiacoliisolatesfromorthopaedicimplantassociatedinfections
‡A
Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections
‡9
1
|
|
919
|
|
|
‡a
measuringhealthvulnerabilityaninterdisciplinaryindicatorappliedtomainlandportugal
‡A
Measuring Health Vulnerability: An Interdisciplinary Indicator Applied to Mainland Portugal
‡9
1
|
|
919
|
|
|
‡a
microanalysisofbioactivesamariumdopedglassreinforcedhydroxyapatite
‡A
Microanalysis of Bioactive Samarium Doped Glass-Reinforced Hydroxyapatite
‡9
1
|
|
919
|
|
|
‡a
micropatternedsilicathinfilmswithnanohydroxyapatitemicroaggregatesforguidedtissueregeneration
‡A
Micropatterned silica thin films with nanohydroxyapatite micro-aggregates for guided tissue regeneration
‡9
1
|
|
919
|
|
|
‡a
modulationofhumandermalmicrovascularendothelialcellandhumangingivalfibroblastbehaviorbymicropatternedsilicacoatingsurfacesforzirconiadentalimplantapplications
‡A
Modulation of human dermal microvascular endothelial cell and human gingival fibroblast behavior by micropatterned silica coating surfaces for zirconia dental implant applications.
‡9
1
|
|
919
|
|
|
‡a
novelceriumdopedglassreinforcedhydroxyapatitewithantibacterialandosteoconductivepropertiesforbonetissueregeneration
‡A
Novel cerium doped glass-reinforced hydroxyapatite with antibacterial and osteoconductive properties for bone tissue regeneration.
‡9
1
|
|
919
|
|
|
‡a
phasebehaviourandmiscibilitystudiesofcollagensilkfibroinmacromolecularsystemindilutesolutionsandsolidstate
‡A
Phase Behaviour and Miscibility Studies of Collagen/Silk Fibroin Macromolecular System in Dilute Solutions and Solid State
‡9
1
|
|
919
|
|
|
‡a
pldbioactiveceramicfilmstheinfluenceofcaop2o5glassadditionstohydroxyapatiteontheproliferationandmorphologyofosteblasticlikecells
‡A
PLD bioactive ceramic films: the influence of CaO-P2O5 glass additions to hydroxyapatite on the proliferation and morphology of osteblastic like-cells.
‡9
1
|
|
919
|
|
|
‡a
proliferationandmineralizationofbonemarrowcellsculturedonmacroporoushydroxyapatitescaffoldsfunctionalizedwithcollagentype1forbonetissueregeneration
‡A
Proliferation and mineralization of bone marrow cells cultured on macroporous hydroxyapatite scaffolds functionalized with collagen type I for bone tissue regeneration
‡9
1
|
|
919
|
|
|
‡a
silkfibroinnanohydroxyapatitehydrogelsforpromotedbioactivityandosteoblasticproliferationanddifferentiationofhumanbonemarrowstromalcells
‡A
Silk fibroin/nanohydroxyapatite hydrogels for promoted bioactivity and osteoblastic proliferation and differentiation of human bone marrow stromal cells
‡9
1
|
|
919
|
|
|
‡a
staphylococcusaureusandescherichiacolidualspeciesbiofilmsonnanohydroxyapatiteloadedwithchxorznonanoparticles
‡A
Staphylococcus aureus and Escherichia coli dual-species biofilms on nanohydroxyapatite loaded with CHX or ZnO nanoparticles.
‡9
1
|
|
919
|
|
|
‡a
staphylococcusaureusandstaphylococcusepidermidisadhesiontonanohydroxyapatiteinthepresenceofmodelproteins
‡A
Staphylococcus aureusandStaphylococcus epidermidisadhesion to nanohydroxyapatite in the presence of model proteins
‡9
1
|
|
919
|
|
|
‡a
supplementationofcollagenscaffoldswithsparctofacilitatemineralization
‡A
Supplementation of collagen scaffolds with SPARC to facilitate mineralization
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
PTBNP|1396122
|
|
996
|
|
|
‡2
LC|n 2019250087
|
|
996
|
|
|
‡2
BNE|XX4950496
|
|
996
|
|
|
‡2
SUDOC|237650835
|
|
996
|
|
|
‡2
BLBNB|001463736
|
|
996
|
|
|
‡2
PTBNP|1768603
|
|
996
|
|
|
‡2
ISNI|0000000105286069
|
|
996
|
|
|
‡2
BLBNB|000308254
|
|
996
|
|
|
‡2
LC|nr 00004623
|
|
996
|
|
|
‡2
LC|n 99902408
|
|
996
|
|
|
‡2
BLBNB|000202978
|
|
996
|
|
|
‡2
DNB|1056313633
|
|
996
|
|
|
‡2
BLBNB|000202974
|
|
996
|
|
|
‡2
BLBNB|000202975
|
|
996
|
|
|
‡2
ISNI|0000000066637144
|
|
996
|
|
|
‡2
DNB|1345883501
|
|
996
|
|
|
‡2
BNE|XX993857
|
|
996
|
|
|
‡2
SUDOC|121897532
|
|
996
|
|
|
‡2
ISNI|0000000373508377
|
|
996
|
|
|
‡2
LC|n 85214090
|
|
996
|
|
|
‡2
BLBNB|000474341
|
|
996
|
|
|
‡2
BLBNB|000536625
|
|
996
|
|
|
‡2
PTBNP|1398373
|
|
996
|
|
|
‡2
NUKAT|n 2006124450
|
|
996
|
|
|
‡2
LC|no2001064041
|
|
996
|
|
|
‡2
ISNI|0000000450556314
|
|
996
|
|
|
‡2
SUDOC|086452215
|
|
996
|
|
|
‡2
PTBNP|1150944
|
|
996
|
|
|
‡2
NTA|406856621
|
|
996
|
|
|
‡2
ISNI|0000000068781588
|
|
996
|
|
|
‡2
PTBNP|1420510
|
|
996
|
|
|
‡2
BLBNB|000517498
|
|
996
|
|
|
‡2
PTBNP|146790
|
|
996
|
|
|
‡2
RERO|A005494313
|
|
996
|
|
|
‡2
DNB|1060759837
|
|
996
|
|
|
‡2
ISNI|0000000068847655
|
|
996
|
|
|
‡2
J9U|987008729543805171
|
|
996
|
|
|
‡2
ISNI|0000000079834008
|
|
996
|
|
|
‡2
DNB|1056457856
|
|
996
|
|
|
‡2
RERO|A027130500
|
|
996
|
|
|
‡2
ISNI|0000000051035095
|
|
996
|
|
|
‡2
BLBNB|000546993
|
|
996
|
|
|
‡2
BNC|981058524815806706
|
|
996
|
|
|
‡2
LC|n 97910271
|
|
996
|
|
|
‡2
LC|no2001066440
|
|
996
|
|
|
‡2
PTBNP|258568
|
|
996
|
|
|
‡2
BLBNB|000501671
|
|
996
|
|
|
‡2
BLBNB|000285047
|
|
996
|
|
|
‡2
NTA|08960007X
|
|
996
|
|
|
‡2
BAV|495_87759
|
|
996
|
|
|
‡2
PTBNP|1260623
|
|
996
|
|
|
‡2
PLWABN|9813993395905606
|
|
996
|
|
|
‡2
LC|n 92024651
|
|
996
|
|
|
‡2
BNF|12080514
|
|
996
|
|
|
‡2
DNB|1176986929
|
|
996
|
|
|
‡2
DNB|1158200757
|
|
996
|
|
|
‡2
PTBNP|219900
|
|
996
|
|
|
‡2
BIBSYS|2094498
|
|
996
|
|
|
‡2
PTBNP|1470640
|
|
996
|
|
|
‡2
ISNI|0000000447779648
|
|
996
|
|
|
‡2
NII|DA18527484
|
|
996
|
|
|
‡2
SUDOC|029547253
|
|
996
|
|
|
‡2
PTBNP|32981
|
|
996
|
|
|
‡2
ISNI|0000000069328312
|
|
996
|
|
|
‡2
SUDOC|077453514
|
|
996
|
|
|
‡2
LC|no 95046507
|
|
996
|
|
|
‡2
BLBNB|000250841
|
|
996
|
|
|
‡2
BNE|XX1109514
|
|
996
|
|
|
‡2
BNF|15293077
|
|
996
|
|
|
‡2
ISNI|0000000108778800
|
|
996
|
|
|
‡2
LC|no2003127776
|
|
996
|
|
|
‡2
PTBNP|1648994
|
|
996
|
|
|
‡2
ISNI|0000000029519835
|
|
996
|
|
|
‡2
LC|n 2008048091
|
|
996
|
|
|
‡2
ISNI|0000000079074627
|
|
996
|
|
|
‡2
ISNI|0000000052568678
|
|
996
|
|
|
‡2
BLBNB|001428644
|
|
996
|
|
|
‡2
ISNI|0000000045771854
|
|
996
|
|
|
‡2
DNB|1056344687
|
|
996
|
|
|
‡2
LC|n 2001067358
|
|
996
|
|
|
‡2
RERO|A000062269
|
|
996
|
|
|
‡2
BLBNB|000340185
|
|
996
|
|
|
‡2
DNB|1057050199
|
|
996
|
|
|
‡2
RERO|A028205660
|
|
996
|
|
|
‡2
LC|no2023023525
|
|
996
|
|
|
‡2
ISNI|0000000072882103
|
|
996
|
|
|
‡2
ISNI|0000000428201816
|
|
996
|
|
|
‡2
ISNI|000000042537982X
|
|
996
|
|
|
‡2
BLBNB|001116140
|
|
996
|
|
|
‡2
BNF|12115054
|
|
996
|
|
|
‡2
SUDOC|121091546
|
|
996
|
|
|
‡2
BNE|XX1173023
|
|
996
|
|
|
‡2
ISNI|0000000038529154
|
|
996
|
|
|
‡2
SUDOC|120782626
|
|
996
|
|
|
‡2
SUDOC|050267426
|
|
996
|
|
|
‡2
SUDOC|115619992
|
|
996
|
|
|
‡2
BLBNB|000370593
|
|
996
|
|
|
‡2
LC|no2001053200
|
|
996
|
|
|
‡2
ISNI|0000000060385097
|
|
996
|
|
|
‡2
PTBNP|1445404
|
|
996
|
|
|
‡2
LC|n 89242955
|
|
996
|
|
|
‡2
PTBNP|1461910
|
|
996
|
|
|
‡2
LC|n 91118848
|
|
996
|
|
|
‡2
PTBNP|1424582
|
|
996
|
|
|
‡2
PTBNP|1527860
|
|
996
|
|
|
‡2
ISNI|0000000069319053
|
|
996
|
|
|
‡2
LC|n 87920306
|
|
996
|
|
|
‡2
PTBNP|1437758
|
|
996
|
|
|
‡2
PTBNP|1373205
|
|
996
|
|
|
‡2
LC|n 96067253
|
|
996
|
|
|
‡2
PTBNP|31866
|
|
996
|
|
|
‡2
BLBNB|001579394
|
|
996
|
|
|
‡2
ISNI|0000000068595080
|
|
996
|
|
|
‡2
LC|no2015002916
|
|
996
|
|
|
‡2
ISNI|0000000068181881
|
|
996
|
|
|
‡2
NKC|jo20191038904
|
|
996
|
|
|
‡2
SUDOC|091556996
|
|
996
|
|
|
‡2
LC|n 2009214383
|
|
996
|
|
|
‡2
ISNI|0000000053616803
|
|
996
|
|
|
‡2
DNB|132751720
|
|
996
|
|
|
‡2
DNB|1133097006
|
|
996
|
|
|
‡2
DNB|1297772865
|
|
996
|
|
|
‡2
ISNI|0000000019577003
|
|
996
|
|
|
‡2
ISNI|0000000046097478
|
|
996
|
|
|
‡2
DNB|133936252
|
|
996
|
|
|
‡2
ISNI|0000000032560097
|
|
996
|
|
|
‡2
RERO|A011108401
|
|
996
|
|
|
‡2
PTBNP|1148924
|
|
996
|
|
|
‡2
BNF|13522174
|
|
996
|
|
|
‡2
ISNI|0000000027275929
|
|
996
|
|
|
‡2
LC|n 2015211010
|
|
996
|
|
|
‡2
BLBNB|000179188
|
|
996
|
|
|
‡2
BLBNB|001470535
|
|
996
|
|
|
‡2
LC|n 2001910201
|
|
996
|
|
|
‡2
BNF|17828663
|
|
996
|
|
|
‡2
ISNI|0000000070911687
|
|
996
|
|
|
‡2
BLBNB|000505421
|
|
996
|
|
|
‡2
DNB|1048643409
|
|
996
|
|
|
‡2
BNF|15299684
|
|
996
|
|
|
‡2
BLBNB|001493817
|
|
996
|
|
|
‡2
LC|n 86839613
|
|
996
|
|
|
‡2
DNB|1056435100
|
|
996
|
|
|
‡2
ISNI|0000000076962549
|
|
996
|
|
|
‡2
PTBNP|1209252
|
|
996
|
|
|
‡2
BLBNB|001461117
|
|
996
|
|
|
‡2
ISNI|0000000073257027
|
|
996
|
|
|
‡2
DNB|1098346882
|
|
996
|
|
|
‡2
ISNI|0000000110006666
|
|
996
|
|
|
‡2
ISNI|0000000070903521
|
|
996
|
|
|
‡2
DNB|12096192X
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Ferraz, Maria Pia de Melo Alvim
‡2
ISNI|0000000069328312
‡3
suggested
|
|
998
|
|
|
‡a
Ferraz,
‡b
Maria Pia de Melo Alvim
‡2
PTBNP|992712
‡3
title: (0.67, 'silkfibroinnanohydroxyapatiteporousscaffoldsforboneregeneration', 'antibacterialsilkfibroinnanohydroxyapatitehydrogelswithsilverandgoldnanoparticlesforboneregeneration')
|
